Oral contraceptive formulation and risk of breast cancer

Contraception

Volumn 85, Issue 4, 2012, Pages 342-350

  Marchbanks, Polly A ^a   Curtis, Kathryn M ^a   Mandel, Michele G ^a   Wilson, Hoyt G ^a   Jeng, Gary ^a   Folger, Suzanne G ^a   McDonald, Jill A ^a   Daling, Janet R ^b   Bernstein, Leslie ^c   Malone, Kathleen E ^b   Wingo, Phyllis A ^a   Simon, Michael S ^d   Norman, Sandra A ^e   Strom, Brian L ^e   Ursin, Giske ^f,g,h   Weiss, Linda K ⁱ   Burkman, Ronald T ^j   Spirtas, Robert ^k  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f CANCER REGISTRY OF NORWAY   (Norway)

^g UNIVERSITY OF OSLO   (Norway)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ NATIONAL CANCER INSTITUTE   (United States)

^j TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k GEORGE WASHINGTON UNIVERSITY   (United States)

more..

Author keywords

Breast cancer; Case control studies; Epidemiology; Hormones; Oral contraceptives

Indexed keywords

ESTROGEN; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORETHISTERONE; ETHINYLESTRADIOL PLUS NORGESTREL; ETYNODIOL DIACETATE PLUS MESTRANOL; GESTAGEN; MESTRANOL PLUS NORETHISTERONE; MESTRANOL PLUS NORETYNODREL; NORETHISTERONE; NORGESTIMATE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CHEMICAL COMPOSITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG FORMULATION; DRUG UTILIZATION; FEMALE; HUMAN; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; POPULATION BASED CASE CONTROL STUDY; RISK ASSESSMENT;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MIDDLE AGED; QUESTIONNAIRES; RISK;

EID: 84858341984     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2011.08.007     Document Type: Article

References (30)

1. W.D. Mosher, and J. Jones Use of contraception in the United States: 1982-2008 Vital Health Stat 23 2010 1 44
2. American Cancer Society Cancer facts & figures 2011 2011 American Cancer Society Atlanta, GA
3. P.A. Marchbanks, J.A. McDonald, and H.G. Wilson Oral contraceptives and the risk of breast cancer N Engl J Med 346 2002 2025 2032 (Pubitemid 34680593)
4. P.A. Marchbanks, J.A. McDonald, and H.G. Wilson The NICHD women's contraceptive and reproductive experiences study: methods and operational results Ann Epidemiol 12 2002 213 221 (Pubitemid 34414934)
5. P.A. Wingo, H.W. Ory, P.M. Layde, N.C. Lee Cancer and Steroid Hormone Study Group The evaluation of the data collection process for a multicenter, population-based, case-control design Am J Epidemiol 128 1988 206 217
6. S.L. West, B.L. Strom, and C. Poole Validity of pharmacoepidemiologic drug and diagnosis data B.L. Strom, 4th ed Pharmacoepidemiology 2005 John Wiley Sussex 709 765
7. Collaborative Group on Hormonal Factors in Breast Cancer Breast cancer and hormonal contraceptives: further results Contraception 54 Suppl 1996 1 106
8. Collaborative Group on Hormonal Factors in Breast Cancer Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies Lancet 347 1996 1713 1727
9. S. Greenland, and D.C. Thomas On the need for the rare disease assumption in case-control studies Am J Epidemiol 116 1982 547 553
10. D.G. Kleinbaum, L.L. Kupper, and H. Morgenstern Epidemiologic research 1982 Lifetime Learning Publications Belmont, California
11. D.J. Hunter, G.A. Colditz, and S.E. Hankinson Oral contraceptive use and breast cancer: a prospective study of young women Cancer Epidemiol Biomarkers Prev 19 2010 2496 2502
12. A.L. Nelson Combined oral contraceptives R.A. Hatcher, J. Trussell, A.L. Nelson, W. Cates, F.H. Stewart, D. Kowal, 19th ed. Contraceptive technology 2007 Ardent Media, Inc. New York 193 270
13. R.P. Dickey Managing contraceptive pill patients 10th ed. 2000 EMIS, Inc. Dallas
14. M.D. Althuis, D.R. Brogan, and R.J. Coates Hormonal content and potency of oral contraceptives and breast cancer risk among young women Br J Cancer 88 2003 50 57 (Pubitemid 36241218)
15. R.A. Hatcher, F. Stewart, and J. Trussell Contraceptive technology 1990-1992 15th ed. 1990 Irvington Publishers, Inc. New York
16. R.A. Hatcher, and J. Guillebaud The pill: combined oral contraceptives R.A. Hatcher, J. Trussell, F. Stewart, Contraceptive technology 17th ed. 1998 Ardent Media, Inc. New York 405 466
17. L.J. Dorflinger Relative potency of progestins used in oral contraceptives Contraception 31 1985 557 570 (Pubitemid 15049777)
18. American Medical Association Drug evaluations 6th ed. 1986 American Medical Association Philadelphia
19. L. Speroff, and P.D. Darney A clinical guide for contraception 3rd ed. 2001 Lippincott Williams & Wilkins Philadelphia
20. Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development Oral contraceptive use and the risk of breast cancer N Engl J Med 315 1986 405 411
21. A. Coulter, M. Vessey, K. McPherson, and B. Crossley The ability of women to recall their oral contraceptive histories Contraception 33 1986 127 137 (Pubitemid 16127121)
22. R.A. Hatcher, F. Guest, F. Stewart, G.K. Stewart, J. Trussell, and E. Frank Contraceptive technology 1984-1985 12th ed. 1984 Irvington Publishers, Inc. New York
23. A.M. Kaunitz Efficacy, cycle control, and safety of two triphasic oral contraceptives: Cyclessa (desogestrel/ethinyl estradiol) and Ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol) Contraception 61 2000 295 302
24. N.E. Davidson, and K.J. Helzlsouer Good news about oral contraceptives (editorial) N Engl J Med 346 2002 2078 2079 (Pubitemid 34680600)
25. Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development The reduction in risk of ovarian cancer associated with oral contraceptive use N Engl J Med 316 1987 650 655
26. Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development Combination oral contraceptive use and the risk of endometrial cancer JAMA 257 1987 796 800
27. Committee on the Relationship Between Oral Contraceptives and Breast Cancer, and Institute of Medicine, Division of Health Promotion and Disease Prevention Oral contraceptives and breast cancer 1991 National Academy Press Washington, DC
28. R.A. Stallones The use and abuse of subgroup analysis in epidemiological research Prev Med 16 1987 183 194 (Pubitemid 17067794)
29. M.A. Klebanoff Subgroup analysis in obstetrics clinical trials Am J Obstet Gynecol 197 2007 119 122 (Pubitemid 47208503)
30. X. Sun, M. Briel, S.D. Walter, and G.H. Guyatt Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses BMJ 340 2010 850 854